2Hiller W, Kief W, Fichter M. How disabled are patients with somatoformdisonlers. Gen Hosp Psychiatry ,1997 ,19:432-481. 被引量：1
3Garyfallos G, AdamopoulouA, Karastergiou A, et al. Somatoform dison-lers :comorbidity with other DSM- HI -Rpsychiatric diagnoses in Greece.Compr Psychiatry,1999 ,40:299-307. 被引量：1
4Russo J, Katon W, Sullivan M ,et al. Severity of somatization and its rela-tion to Dsvchiatric disorders and personality. Psvchosomatics, 1994,35 :546-556. 被引量：1
5Lipow ZL. San atization the conceptand its clinical application. Am J Psy-chiatry ,1988 ,145 : 1358. 被引量：1
6Rief W,Hessel A,Braehler E.Somatization symptom and hypochondriacal features in general population.Psychomsom Med,2001,63:595-602. 被引量：2
7Lenze EJ,Miller AR,Munir ZB,et al.Psychiatric symptoms endorsed by somatization disorder patients in a psychiatric clinic.Ann Clin Psychiatry,1999,11:73-79. 被引量：1
8Volz HP,Moller HJ,Reimann I,et al.Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial.Eur Neuropsychopharmacol,2000,10:211-217. 被引量：1
9Esa L,Ulla L,Hannu K.Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial.J Psychiatry Neurosci,2000,25:24-32. 被引量：1
10Rief W,Pilger F,Ihle D,et al.Psychobiological aspects of somatoform disorders: contributions of monoaminergic transmitter systems.Neuropsychobiology,2004,49:24-29. 被引量：1
4Raskin J,Wiltse CG, Siegal A, et al. Efficacy of duloxetine on cog-ni- tion, depression, and pain in elderly patients with major depressivedisor- der: an 8-week, double-blind, placebo-controlled trial [ J ]. AmJ Psychia- try ,2007,164 (6) :900 - 909. 被引量：1
5Goldstein DJ, Lu Y, Detke MJ, et al. Effects of duloxetine onpainful physical symptoms associated with depression [ J ]. Psycho-somalics, 2004,54 : 17 - 28. 被引量：1
6Mallinckrodt C, Goldstein DJ, Detke MJ, et al. Duloxetine : Anew treat- ment for the emotional and physical symp-toms ofdepression [ J ]. J Clin Psychiatry ,2003 ;64 (5) : 19 - 20. 被引量：1
7Goldstein DJ,Mallinckrodt C, Lu Y,et al. Duloxetine in thetreatment of major depressive disorder: a double-blind clini-cal trial [ J ]. J Clin Psy- chiatry ,2002 ;63 (3) :225 -231. 被引量：1
8Rabassedax. Duloxetine:a new semtonim/noradrenaline re-uptake inhibi- tor for the treatment of depression [ J ]. Drugs Today ( Bare ), 2004,40 : 773 - 790. 被引量：1
